These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9587965)
21. Pregnancy and the risk of teratogenicity. Lindhout D; Omtzigt JG Epilepsia; 1992; 33 Suppl 4():S41-8. PubMed ID: 1425493 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of therapeutic drug monitoring of antiepileptic drugs. Irshaid YM; Hamdi AA; Al Homrany M Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161 [TBL] [Abstract][Full Text] [Related]
23. Neuropsychological effects in children exposed to anticonvulsant monotherapy during gestation: Phenobarbital, carbamazepine, and phenytoin. Adams J; Janulewicz PA; Macklin EA; Dhillon R; Phillips C; Schomer DL; Tosches WA; Carlson JM; Holmes LB Epilepsy Behav; 2022 Feb; 127():108533. PubMed ID: 35042158 [TBL] [Abstract][Full Text] [Related]
24. Interaction profile of Zizyphus jujuba with phenytoin, phenobarbitone, and carbamazepine in maximal electroshock-induced seizures in rats. Pahuja M; Kleekal T; Reeta KH; Tripathi M; Gupta YK Epilepsy Behav; 2012 Nov; 25(3):368-73. PubMed ID: 23103312 [TBL] [Abstract][Full Text] [Related]
25. [Problems of neurological drug therapy in pregnancy]. Piccione E; Ticconi C; Cennamo M Clin Ter; 1989 Apr; 129(2):139-44. PubMed ID: 2526000 [No Abstract] [Full Text] [Related]
26. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Zeng K; Wang X; Xi Z; Yan Y Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075 [TBL] [Abstract][Full Text] [Related]
27. Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia. Danielsson BR; Sköld AC; Johansson A; Dillner B; Blomgren B Toxicol Appl Pharmacol; 2003 Dec; 193(2):168-76. PubMed ID: 14644619 [TBL] [Abstract][Full Text] [Related]
28. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430 [TBL] [Abstract][Full Text] [Related]
29. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257 [TBL] [Abstract][Full Text] [Related]
30. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation. Finnell RH; Bennett GD; Slattery JT; Amore BM; Bajpai M; Levy RH Teratology; 1995 Dec; 52(6):324-32. PubMed ID: 8711619 [TBL] [Abstract][Full Text] [Related]
31. Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin. Yamamura S; Hamaguchi T; Ohoyama K; Sugiura Y; Suzuki D; Kanehara S; Nakagawa M; Motomura E; Matsumoto T; Tanii H; Shiroyama T; Okada M Epilepsy Res; 2009 Apr; 84(2-3):172-86. PubMed ID: 19268540 [TBL] [Abstract][Full Text] [Related]
32. Developmental toxicity of the class III antiarrhythmic agent almokalant in mice. Adverse effects mediated via induction of embryonic heart rhythm abnormalities. Sköld AC; Danielsson BR Arzneimittelforschung; 2000 Jun; 50(6):520-5. PubMed ID: 10918943 [TBL] [Abstract][Full Text] [Related]
33. Congenital malformations due to antiepileptic drugs. Kaneko S; Battino D; Andermann E; Wada K; Kan R; Takeda A; Nakane Y; Ogawa Y; Avanzini G; Fumarola C; Granata T; Molteni F; Pardi G; Minotti L; Canger R; Dansky L; Oguni M; Lopes-Cendas I; Sherwin A; Andermann F; Seni MH; Okada M; Teranishi T Epilepsy Res; 1999 Feb; 33(2-3):145-58. PubMed ID: 10094426 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of antiepileptic drugs in elderly nursing home residents. Birnbaum AK Int Rev Neurobiol; 2007; 81():211-20. PubMed ID: 17433926 [TBL] [Abstract][Full Text] [Related]
35. Chronic antiepileptic drug therapy: classification by medication regimen and incidence of decreases in serum thyroxine and free thyroxine index. Haidukewych D; Rodin EA Ther Drug Monit; 1987 Dec; 9(4):392-8. PubMed ID: 3424405 [TBL] [Abstract][Full Text] [Related]
36. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F; Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013 [TBL] [Abstract][Full Text] [Related]
37. Comparative stroke risk of antiepileptic drugs in patients with epilepsy. Hsieh CY; Lai EC; Yang YH; Lin SJ Epilepsia; 2013 Jan; 54(1):172-80. PubMed ID: 23030457 [TBL] [Abstract][Full Text] [Related]
38. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335 [TBL] [Abstract][Full Text] [Related]
39. Antiepileptic drug teratogenesis: what are the risks for congenital malformations and adverse cognitive outcomes? Harden CL Int Rev Neurobiol; 2008; 83():205-13. PubMed ID: 18929083 [TBL] [Abstract][Full Text] [Related]